Head-To-Head Comparison: DS Healthcare Group (DSKX) vs. Nautilus Group, Inc. (The) (NLS)
DS Healthcare Group (NASDAQ: DSKX) and Nautilus Group, Inc. (The) (NYSE:NLS) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership.
Institutional & Insider Ownership
8.5% of DS Healthcare Group shares are held by institutional investors. Comparatively, 97.7% of Nautilus Group, Inc. (The) shares are held by institutional investors. 19.4% of DS Healthcare Group shares are held by insiders. Comparatively, 3.7% of Nautilus Group, Inc. (The) shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Volatility and Risk
DS Healthcare Group has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, Nautilus Group, Inc. (The) has a beta of 2.15, suggesting that its stock price is 115% more volatile than the S&P 500.
This is a summary of recent recommendations and price targets for DS Healthcare Group and Nautilus Group, Inc. (The), as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|DS Healthcare Group||0||0||0||0||N/A|
|Nautilus Group, Inc. (The)||0||0||6||0||3.00|
Nautilus Group, Inc. (The) has a consensus price target of $22.67, indicating a potential upside of 34.52%. Given Nautilus Group, Inc. (The)’s higher possible upside, analysts clearly believe Nautilus Group, Inc. (The) is more favorable than DS Healthcare Group.
This table compares DS Healthcare Group and Nautilus Group, Inc. (The)’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|DS Healthcare Group||-104.81%||N/A||-196.55%|
|Nautilus Group, Inc. (The)||7.25%||17.22%||8.93%|
Earnings & Valuation
This table compares DS Healthcare Group and Nautilus Group, Inc. (The)’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|DS Healthcare Group||N/A||N/A||N/A||($0.77)||-0.03|
|Nautilus Group, Inc. (The)||$396.86 million||1.31||$52.78 million||$0.92||18.32|
Nautilus Group, Inc. (The) has higher revenue and earnings than DS Healthcare Group. DS Healthcare Group is trading at a lower price-to-earnings ratio than Nautilus Group, Inc. (The), indicating that it is currently the more affordable of the two stocks.
Nautilus Group, Inc. (The) beats DS Healthcare Group on 9 of the 10 factors compared between the two stocks.
About DS Healthcare Group
DS Healthcare Group, Inc., doing business as DS Laboratories, is a personal care, product development and marketing company. The Company develops and markets branded personal care products that address thinning hair conditions, skin care and other personal care needs. It develops technologies and products for hair care and personal care needs. Its technologies include Liposome Technology, which acts as a carrier agent, and is designed to enhance the act ion of the active ingredients in its products, and Nanosome Technology, which acts as a delivery vehicle, and is designed to infuse active compounds into targeted cells. The Company products are primarily sold under its DS Laboratories brand. It also sells certain products under its Polaris Labs and Sigma Skin brands. It markets and sells these products through salons, spas, department stores, specialty retailers and distributors. The Company offers products under three product categories: Hair Care, Skin Care and Personal Care.
About Nautilus Group, Inc. (The)
Nautilus, Inc. is a consumer fitness products company. The Company operates through two segments: Direct and Retail. Its principal business activities include designing, developing, sourcing and marketing of cardio and strength fitness products and related accessories for consumer use, primarily in the United States and Canada, but also in international markets outside North America. The Direct business offers products directly to consumers through television advertising, catalogs and the Internet. In its Direct business, the Company markets and sells its products, principally Bowflex cardio and strength products, directly to consumers. The Retail business offers its products through a network of independent retail companies and specialty retailers with stores and Websites located in the United States and internationally. In its Retail business, the Company markets and sells a line of consumer fitness equipment under the Nautilus, Octane Fitness, Schwinn, Universal and Bowflex brands.
Receive News & Ratings for DS Healthcare Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DS Healthcare Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.